- Home
- SOHO vs INKT Comparison
SOHO vs INKT Comparison
Compare SOHO & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOHO | INKT |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9M | 51.7M |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SOHO | INKT |
|---|---|---|
| Price | $2.16 | $11.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 63.6K | 19.9K |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $177,571,118.00 | N/A |
| Revenue This Year | $13.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.59 | $4.56 |
| 52 Week High | $2.20 | $76.00 |
Technical Indicators
Market Signals| Indicator | SOHO | INKT |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 47.84 |
| Support Level | $2.16 | $11.55 |
| Resistance Level | $2.20 | $12.68 |
| Average True Range (ATR) | 0.02 | 0.83 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 25.00 | 49.47 |
Price Performance
Historical ComparisonAbout SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.